KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Repligen (RGEN) EBIAT (2016 - 2025)

Repligen (RGEN) has disclosed EBIAT for 16 consecutive years, with $13.3 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT rose 139.23% to $13.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $48.9 million, a 291.64% increase, with the full-year FY2025 number at $48.9 million, up 291.64% from a year prior.
  • EBIAT was $13.3 million for Q4 2025 at Repligen, down from $14.9 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $49.9 million in Q2 2022 to a low of -$33.9 million in Q4 2024.
  • A 5-year average of $18.0 million and a median of $15.1 million in 2023 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: crashed 133.76% in 2023, then surged 2379.97% in 2025.
  • Repligen's EBIAT stood at $29.1 million in 2021, then skyrocketed by 67.4% to $48.7 million in 2022, then tumbled by 133.76% to -$16.4 million in 2023, then tumbled by 105.89% to -$33.9 million in 2024, then skyrocketed by 139.23% to $13.3 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's EBIAT are $13.3 million (Q4 2025), $14.9 million (Q3 2025), and $14.9 million (Q2 2025).